2006

Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V: Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts. Am J Pathol. 2006 Dec; 169(6):1939-52.

Rosenzweig M, Skinner M, Prokaeva T, Theberge R, Costello C, Drachman BN, Connors LH: A new transthyretin variant Glu-61-Gly associated with cardiomyopathy.  Amyloid: J Prot Folding Disorders, in press, 2006.

Sanchorawala V: Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006 Nov; 1 (6): 1331-41.

Sanchorawala V, Blanchard E, Seldin DC, O’Hara C, Skinner M, Wright DG. AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes. American Journal of Hematology 2006; 81: 692-695

Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: Results of a phase II trial., Blood, 2006 Sep 7; [Epub ahead of print]

Sawyer, D, Skinner M: Cardiac Amyloidosis: Shifting Our Impressions to Hopeful.  Curr Heart Fail Rep., 3(2): 64-71, 2006.

Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Oran B, and Skinner M. Successful treatment of AL Amyloidosis with high dose melphalan and autologous stem cell transplantation in patients over age 65. Blood. 2006 Dec. 1; 108(12):3945-7.

Weichman K, Dember LD, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, and Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. BMT 2006, 38(5):339-343.